Barriers and adherence to glaucoma medication in a paediatric glaucoma population: A cross-sectional survey in

Amirah Al-Dawood1, Khabir Ahmad1, Salma Al-Salman1

  • 146670King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.

Insights

Pediatric glaucoma patients in Saudi Arabia show poor adherence to topical medications. Key barriers include forgetfulness, complex dosing, and busy schedules, impacting treatment effectiveness.

Area of Science:

  • Ophthalmology
  • Pediatric Medicine
  • Public Health

Background:

  • Glaucoma is a leading cause of irreversible blindness in children.
  • Topical medications are crucial for managing pediatric glaucoma but adherence can be challenging.
  • Understanding barriers to adherence is vital for improving treatment outcomes in this vulnerable population.

Purpose of the Study:

  • To investigate the barriers affecting adherence to topical glaucoma medication in children in Saudi Arabia.
  • To assess the reliability and validity of a tool designed to measure these barriers.
  • To identify specific factors associated with missed medication doses.

Main Methods:

  • A cross-sectional study involving 106 parents of children (6 months to 15 years) with glaucoma in Riyadh, Saudi Arabia.
  • Utilized a 12-item barriers-to-adherence tool (BAT-12) with Rasch analysis for psychometric evaluation.
  • Assessed medication adherence through parent-reported frequency of missed doses and analyzed determinants using Poisson regression.

Main Results:

  • The BAT-12 demonstrated acceptable psychometric properties.
  • Forgetfulness, complex dosing regimens, and busy schedules were identified as significant barriers.
  • Over a third of parents (34.9%) reported missing at least one day of medication administration in the past three days.
  • Increased child age and higher parent-reported barriers score were significantly associated with missed medications.

Conclusions:

  • The developed barriers-to-adherence tool is a valid instrument for assessing adherence challenges in pediatric glaucoma.
  • Poor adherence to topical glaucoma medications is a significant issue in the studied pediatric population.
  • Addressing identified barriers is crucial for optimizing glaucoma management in children.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
691
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
818
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
892
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
379
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
4.3K